IPR Details
DoCoMo USA Labs' Statement about IPR claimed in draft-kempf-mobopts-ringsig-ndproxy-00.txt

The text of the original IPR disclosure is available in the disclosure history.

Submitted: August 3, 2005 under the rules in RFC 3979

Note: Updates to IPR disclosures must only be made by authorized representatives of the original submitters. Updates will automatically be forwarded to the current Patent Holder's Contact and to the Submitter of the original IPR disclosure.

I. Patent Holder/Applicant ("Patent Holder")

Holder legal name DoCoMo USA Labs

II. Patent Holder's Contact for Licence Application

Holder contact name Toshiro Kawahara
Holder contact email kawahara@docomolabs-usa.com
Holder contact info

Senior Vice President
DoCoMo Communications Laboratories USA, Inc.

III. IETF Document or Other Contribution to Which this IPR Disclosure Relates

Internet-Draft: draft-kempf-mobopts-ringsig-ndproxy ("Secure IPv6 Address Proxying using Multi-Key Cryptographically Generated Addresses (MCGAs)")

IV. Licensing Declaration

The Patent Holder states that its position with respect to licensing any patent claims contained in the patent(s) or patent application(s) disclosed above that would necessarily be infringed by implementation of the technology required by the relevant IETF specification ("Necessary Patent Claims"), for the purpose of implementing such specification, is as follows(select one licensing declaration option only):

Licensing See Text Below for Licensing Declaration
Licensing information, comments, notes, or URL for further information

* DoCoMo Communications Laboratories USA, Inc. (DoCoMo USA Labs)
will not assert its US Patent or its non-US
counterpart against any party that implements draft-kempf-
mobopts-ringsig-ndproxy-00.txt or any derivative, when this
is employed as a standard.

This grant of rights will terminate with respect to any party
that asserts a patent it owns, directly or indirectly, against
DoCoMo USA Labs and affiliates for their implementation and
operation in compliance with this technology or any derivative.
This termination will occur as of the date the patent is
asserted against DoCoMo USA Labs and affiliates.

Note: The individual submitting this template represents and warrants that he or she is authorized by the Patent Holder to agree to the above-selected licensing declaration.

V. Contact Information of Submitter of this Form

Submitter name
Submitter email

Only those sections of the relevant entry form where the submitter provided information are displayed.